3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
63
Phase 1
34
Phase 1/2
27
Phase 3
21
Phase NA
5
Phase 2/3
3
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
34
Lymphoid
21
Myeloid
1
Conditions
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
nilotinib
12
Imatinib Mesylate
11
Dasatinib
3
ruxolitinib
2
posaconazole
2
fludarabine
2
bosutinib
2
asciminib
2
Cyclophosphamide
2
Busulfan
2
zanubrutinib
1
trametinib
1
pegaspargase
1
flumatinib
1
fludarabine phosphate
1
eltrombopag
1
dabrafenib
1
avapritinib
1
Thiotepa
1
Rituximab
1
Radiotherapy
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Micafungin
1
Interferons
1
Idarubicin
1
Hydroxyurea
1
Growth Hormone
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cytarabine
×
Myeloid
×
Clear all
NCT00487448
2008-11-19
FLAG-IDA
PETHEMA Foundation
Phase 4
Completed
200 enrolled